| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 75-84, Copyright © 1995 by Endocrine Society
ARTICLES |
D Pati and HR Habibi
Department of Biological Sciences, University of Calgary, Alberta, Canada.
This study provides the first demonstration that human hepatocarcinoma- derived cell line HepG2 contains GnRH receptors and responds to various molecular forms of GnRH in terms of inhibition of proliferation in a time- and dose-related manner. In addition, GnRH peptides also significantly inhibited the uptake of [3H]thymidine by these cells. The effect of GnRH was specific because GnRH antagonists reversed the GnRH- mediated inhibition, and non-GnRH peptides had no effect on HepG2 cell proliferation. An important finding is that certain fish GnRH molecules such as lamprey GnRH, which has little gonadotropin (LH) release activity in mammals, suppress hepatocarcinoma cell proliferation with similar potency to a superactive mammalian GnRH analog, [D-Lys6]GnRH. These findings may have profound implications in the development of an effective chemotherapy for treatment of human liver cancer. An added advantage is that fish GnRH forms will likely exert little side effect in terms of human pituitary gonadotropin release, gonadal steroidogenesis, and reproductive functions in general.
This article has been cited by other articles:
![]() |
R. Mancinelli, P. Onori, E. Gaudio, S. DeMorrow, A. Franchitto, H. Francis, S. Glaser, G. Carpino, J. Venter, D. Alvaro, et al. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1 Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G11 - G26. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morgan, A. J. Stewart, N. Miller, P. Mullen, M. Muir, M. Dodds, F. Medda, D. Harrison, S. Langdon, and R. P. Millar Gonadotropin-Releasing Hormone Receptor Levels and Cell Context Affect Tumor Cell Responses to Agonist In vitro and In vivo Cancer Res., August 1, 2008; 68(15): 6331 - 6340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Wilson, M S. Salamat, R. J Haasl, K. M Roche, A. Karande, S. V. Meethal, E. Terasawa, R. L Bowen, and C. S Atwood Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression J. Endocrinol., December 1, 2006; 191(3): 651 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nagy and A. V. Schally Targeting of Cytotoxic Luteinizing Hormone-Releasing Hormone Analogs to Breast, Ovarian, Endometrial, and Prostate Cancers Biol Reprod, November 1, 2005; 73(5): 851 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Halmos, and J. B. Engel Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues Clin. Cancer Res., August 1, 2005; 11(15): 5549 - 5557. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Westphal, G. Halmos, and J. B. Engel Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue Cancer Res., July 1, 2005; 65(13): 5857 - 5863. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.A. Bramley, H.P. Boyle, and G.S. Menzies Human placental GnRH-like factors: parallel displacement in GnRH immuno- and receptor-binding assays can be caused by degradation of radiolabelled GnRH tracers Mol. Hum. Reprod., December 1, 1999; 5(12): 1095 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pati and H. R. Habibi Presence of Salmon Gonadotropin-Releasing Hormone (GnRH) and Compounds with GnRH-Like Activity in the Ovary of Goldfish Endocrinology, April 1, 1998; 139(4): 2015 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nechushtan, S. Yarkoni, I. Marianovsky, and H. Lorberboum-Galski Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites J. Biol. Chem., April 25, 1997; 272(17): 11597 - 11603. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |